siRNA treatment reduces triglycerides in people with unusual problem

.ANALYSIS HIGHLIGHT.19 September 2024.

Plozasiran minimized triglyceride levels through 80% and also reduced the threat of pancreatitis in clients along with constant chylomicronemia, along with or without a hereditary medical diagnosis.